Januvia
✅ Manages blood sugar levels
✅ Enhances insulin production
✅ Supports diabetes management
✅ Convenient once-daily dosing
✅ Improves overall glycemic control
Januvia contains Sitagliptin
✓ Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience · Last reviewed: May 2026
⚡ Quick Answer — What is Januvia?
Januvia is a brand of sitagliptin (25 mg, 50 mg or 100 mg), a DPP-4 inhibitor (dipeptidyl peptidase-4 inhibitor, also called a “gliptin”) used for type 2 diabetes. It works by blocking the enzyme DPP-4, which normally breaks down incretin hormones (GLP-1 and GIP). Higher incretin levels stimulate insulin release and suppress glucagon only when blood glucose is high — so DPP-4 inhibitors produce a glucose-dependent effect and do not cause hypoglycaemia as monotherapy. HbA1c reduction: 0.6–0.8 points. Weight-neutral. Once-daily dosing (most gliptins). Longest track record of any gliptin; widely prescribed first-choice DPP-4 inhibitor. Cardiovascular-neutral in the TECOS outcome trial (no increase or decrease in MACE). Dose: 100 mg once daily. Dose-reduce in renal impairment: 50 mg/day if eGFR 30–45, 25 mg/day if eGFR < 30. Main side effects are mild — upper respiratory symptoms, headache, rare pancreatitis. Avoid in type 1 diabetes and DKA.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.
What Is Januvia?
Januvia is an oral antidiabetic medicine containing sitagliptin (25 mg, 50 mg or 100 mg), manufactured by Merck & Co. Available in packs of 28, 56 or 84 tablets. It is prescribed for adults with type 2 diabetes, usually alongside metformin or as a second- or third-line agent.
sitagliptin belongs to the DPP-4 inhibitor (“gliptin”) class — first approved 2006 — the first DPP-4 inhibitor approved (originator brand: Januvia, Merck). Gliptins are widely used because they are weight-neutral, have a low hypoglycaemia risk, and can be used across the renal spectrum with appropriate dose adjustment.
How Does Januvia Work?
After meals, the gut releases two incretin hormones — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones tell the pancreas to release insulin and the liver to suppress glucagon, but they are rapidly broken down by the enzyme dipeptidyl peptidase-4 (DPP-4) within minutes.
sitagliptin blocks DPP-4. This raises active GLP-1 and GIP levels, producing:
- Glucose-dependent insulin release from pancreatic beta cells — only when blood glucose is elevated
- Suppression of glucagon from alpha cells, reducing hepatic glucose output after meals
- Modest slowing of gastric emptying
Because insulin release is glucose-dependent, DPP-4 inhibitors do not cause hypoglycaemia on their own. Typical HbA1c reduction: 0.6–0.8 percentage points. Weight effect: neutral. Blood pressure and lipid effects: neutral.
Dosage and Administration
Standard dose: 100 mg once daily. Dose-reduce in renal impairment: 50 mg/day if eGFR 30–45, 25 mg/day if eGFR < 30. Januvia can be taken with or without food.
- Once-daily dosing (twice for vildagliptin) — pick a consistent time.
- Half-life and excretion: 12 hours; ~80% renally excreted unchanged.
- Renal dosing: Full dose if eGFR > 45; reduce to 50 mg if eGFR 30–45; reduce to 25 mg if eGFR < 30 or dialysis. Can be used across the renal spectrum with dose adjustment.
- No hepatic dose adjustment for most gliptins (vildagliptin needs baseline ALT check).
- Miss a dose — skip it; take the next at the usual time. Do not double up.
Side Effects
DPP-4 inhibitors are among the best-tolerated oral antidiabetics. Most side effects are mild and similar across the class.
Common:
- Upper respiratory tract infection, nasopharyngitis
- Headache
- Mild GI upset — nausea, diarrhoea (less common than with metformin)
Uncommon but important:
- Acute pancreatitis — rare but documented class effect; stop immediately if severe abdominal pain develops
- Severe joint pain (arthralgia) — can occur weeks to months after starting; usually resolves on discontinuation
- Hypersensitivity / angioedema — bullous pemphigoid has been reported; stop if blistering skin lesions develop
- Saxagliptin specifically: small increase in hospitalisation for heart failure
- Vildagliptin specifically: rare hepatic enzyme elevations — monitor ALT
As monotherapy, hypoglycaemia is very rare. When combined with sulfonylureas or insulin, those agents’ doses may need reducing.
Drug Interactions
- Sulfonylureas, insulin, meglitinides — additive glucose-lowering. Expect to reduce these doses when adding a gliptin.
- Strong CYP3A4/5 inhibitors (ketoconazole, clarithromycin, ritonavir, atazanavir) — raise saxagliptin levels; halve the saxagliptin dose. Minimal effect on sitagliptin, linagliptin, vildagliptin.
- Rifampicin — reduces linagliptin levels modestly; effect may be clinically meaningful.
- ACE inhibitors — theoretical additive angioedema risk; clinical significance debated.
- Digoxin — small rise in peak level with sitagliptin; usually not clinically important.
Who Should Not Take Januvia?
- Type 1 diabetes mellitus
- Diabetic ketoacidosis
- Known hypersensitivity to sitagliptin or other DPP-4 inhibitors
- History of pancreatitis (relative — discuss alternatives)
- Pregnancy and breastfeeding — data limited; alternatives preferred
- Saxagliptin specifically: severe heart failure
- Vildagliptin specifically: ALT or AST > 3× upper limit of normal
Storage
Store Januvia below 30°C in a dry place, in the original blister. Keep out of reach of children.
Frequently Asked Questions
Is Januvia the same as sitagliptin?
Yes. Januvia contains the same active ingredient as the originator brand. Bioequivalence is required by regulatory authorities, so clinical effect is the same at the same dose.
How does sitagliptin compare to linagliptin or vildagliptin?
All DPP-4 inhibitors have similar HbA1c effect (0.6–0.8 points). Linagliptin does not need dose adjustment in renal impairment, so it is preferred in CKD. Vildagliptin is twice daily and requires baseline ALT monitoring. Sitagliptin has the largest outcome-trial dataset.
Will Januvia cause low blood sugar?
On its own, no. DPP-4 inhibitors act in a glucose-dependent manner — they only augment insulin release when blood glucose is high. Hypoglycaemia only becomes a concern when Januvia is combined with a sulfonylurea, meglitinide, or insulin.
Does Januvia cause weight gain?
No — DPP-4 inhibitors are weight-neutral. This is one of the main reasons they are preferred over sulfonylureas in overweight patients.
Can Januvia cause pancreatitis?
Acute pancreatitis is a rare but documented class effect. The absolute risk is small, and large trials (TECOS, CARMELINA, SAVOR) have generally shown no statistically significant excess. Stop immediately and seek medical attention if severe abdominal pain develops — especially pain radiating to the back.
How long does Januvia take to work?
Fasting glucose starts to fall in the first week. Maximal HbA1c effect is at 12 weeks. If HbA1c has not fallen by at least 0.3–0.5% after 3 months, a different second agent (SGLT-2 inhibitor or GLP-1 agonist) should be considered.
Can I stop Januvia suddenly if I don’t feel well?
Yes — DPP-4 inhibitors can be stopped abruptly without rebound hyperglycaemia. If you develop severe abdominal pain, skin blistering, or severe joint pain, stop and contact your doctor.
Where can I buy Januvia online?
You can order Januvia (25 mg, 50 mg or 100 mg) from MedsBase in packs of 28, 56 or 84 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.
Related Diabetes Medications
- Januvia — Sitagliptin 25/50/100 mg (Merck)
- Trajenta — Linagliptin 5 mg (Boehringer Ingelheim)
- Galvus — Vildagliptin 50 mg (Novartis)
- Janumet — Sitagliptin + Metformin combo
- Jardiance — Empagliflozin (SGLT-2 alternative)
- Glycomet SR — Metformin sustained-release
- Browse all Diabetes Medications
Related Alternatives
Other products in Chronic Conditions that customers also view:
More options in Diabetes
Ranked by recent MedsBase order volume — what other customers in this category are picking.
| Strength | 25 mg, 50 mg, 100 mg |
|---|---|
| Quantity | 28 Tablet/s, 56 Tablet/s, 84 Tablet/s |
| Pharma Form | Tablet/s |
| Manufacturer | Merck & Co |
| Treatment | Type 2 diabetes |
Januvia
Spørgsmål & svar
Januvia
Relaterede produkter
Anmeldelser
Der er ingen anmeldelser endnu